Bionor Pharma ASA completed extraordinary general meeting and the announcement earlier regarding completion of the acquisition of the entire share capital of Solon Eiendom AS. With effect from 15 December 2016, the new Board of Directors of the Company will consist of: Simen Thorsen, chairman; Einar J. Greve, deputy chairman; Tore Aksel Voldberg, board member; Bente Bøhler, board member; Katarina Finneng, board member. The new Board of Directors was elected by the shareholders at the extraordinary general meeting held on 14 December 2016.

Further, the Board of Directors of the Company has appointed Mr. Andreas Martinussen as the Company's Chief Executive Officer (CEO) and Mr. Tarjei Røise Warholm as the Company's Chief Financial Officer (CFO). They will both take over the responsibilities as CEO and CFO as of 15 December 2016.